These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 33166303)
1. Monitor for COVID-19 vaccine resistance evolution during clinical trials. Kennedy DA; Read AF PLoS Biol; 2020 Nov; 18(11):e3001000. PubMed ID: 33166303 [TBL] [Abstract][Full Text] [Related]
2. Understanding COVID-19 vaccine efficacy. Lipsitch M; Dean NE Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460 [No Abstract] [Full Text] [Related]
3. Keeping track of the SARS-CoV-2 vaccine pipeline. Parker EPK; Shrotri M; Kampmann B Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290 [TBL] [Abstract][Full Text] [Related]
4. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related]
5. COVID-19: The race for a vaccine. Lockey E J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926902. PubMed ID: 32404020 [No Abstract] [Full Text] [Related]
6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]
7. The COVID-19 vaccine development landscape. Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591 [No Abstract] [Full Text] [Related]
8. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468 [No Abstract] [Full Text] [Related]
9. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
10. A vaccine is not too far for COVID-19. Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830 [No Abstract] [Full Text] [Related]
11. The Race to Develop a COVID-19 Vaccine. Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132 [TBL] [Abstract][Full Text] [Related]
12. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes. Cyranoski D Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453 [No Abstract] [Full Text] [Related]
13. Advances in skin science enable the development of a COVID-19 vaccine. Falo LD J Am Acad Dermatol; 2020 Oct; 83(4):1226-1227. PubMed ID: 32485211 [No Abstract] [Full Text] [Related]
14. COVID-19 vaccine design: the Janus face of immune enhancement. Hotez PJ; Corry DB; Bottazzi ME Nat Rev Immunol; 2020 Jun; 20(6):347-348. PubMed ID: 32346094 [TBL] [Abstract][Full Text] [Related]
15. What the immune response to the coronavirus says about the prospects for a vaccine. Ledford H Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981 [No Abstract] [Full Text] [Related]
17. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Gaebler C; Nussenzweig MC Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943 [No Abstract] [Full Text] [Related]
18. Vaccine Against Covid-19 Disease - Present Status of Development. Dutta AK Indian J Pediatr; 2020 Oct; 87(10):810-816. PubMed ID: 32880819 [TBL] [Abstract][Full Text] [Related]
19. Inclusion of pregnant women in COVID-19 vaccine development. Heath PT; Le Doare K; Khalil A Lancet Infect Dis; 2020 Sep; 20(9):1007-1008. PubMed ID: 32795409 [No Abstract] [Full Text] [Related]
20. How the pandemic might play out in 2021 and beyond. Scudellari M Nature; 2020 Aug; 584(7819):22-25. PubMed ID: 32760050 [No Abstract] [Full Text] [Related] [Next] [New Search]